Looking for volunteers
Modular Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer
NCT07888140 · Ruijin Hospital · Updated 22 Oct 2026
- What is being tested
- Modular Robot-Assisted Esophagectomy; Conventional Minimally Invasive Esophagectomy
- For
- Esophageal Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 3.
- Who can join
- Ages 18 years and older. About 160 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 15 Oct 2026, ends 30 Oct 2031. Registered 22 Oct 2026.
- Results
- None posted yet.
In the researchers' words
This study evaluates the safety, efficacy, and health economic outcomes of modular robotic-assisted minimally invasive esophagectomy (RAMIE) compared with conventional thoracoscopic minimally invasive esophagectomy (MIE) in patients with resectable esophageal cancer. Participants are randomly assigned in a 1:1 ratio to undergo either modular robotic-assisted esophagectomy using the Carina™ Surgical Platform (experimental group) or conventional thoracoscopic esophagectomy (control group). The primary endpoint is the rate of Textbook Outcome (TO) within 30 days post-operation. Secondary endpoints include operative parameters, quality of life, overall survival, disease-free survival, and health economic metrics.
Sites
- Ruijin Hospital, Shanghai Jiao Tong University School of MedicineShanghai, China